Concepedia

Laura García‐Toscano

LG

7

Publications

249

Citations

7

H-Index

2016

Active since

Affiliations

Universidad Complutense de Madrid(Current)

Biomedical Research Networking Center on Neurodegenerative Diseases

Instituto Ramón y Cajal de Investigación Sanitaria

University of Córdoba

Instituto Maimónides de Investigación Biomédica de Córdoba

Laura García‐Toscano is an author at Universidad Complutense de Madrid specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

2016–2021

7

Publications

7

Targeting glial cannabinoid <scp>CB<sub>2</sub></scp> receptors to delay the progression of the pathological phenotype in <scp>TDP‐43</scp> (<scp>A315T</scp>) transgenic mice, a model of amyotrophic lateral sclerosis

Francisco Espejo‐Porras, Laura García‐Toscano, Carmen Rodríguez‐Cueto et al. · British Journal of Pharmacology · 2018 · 77 citations · Full text

Neuroprotective effects of the cannabigerol quinone derivative VCE-003.2 in SOD1G93A transgenic mice, an experimental model of amyotrophic lateral sclerosis

Carmen Rodríguez‐Cueto, Irene Santos‐García, Laura García‐Toscano et al. · Biochemical Pharmacology · 2018 · 59 citations

, , +7

Cannabidiol Administration Prevents Hypoxia-Ischemia-Induced Hypomyelination in Newborn Rats

María Ceprián, Carlos Vargas, Laura García‐Toscano et al. · Frontiers in Pharmacology · 2019 · 36 citations · Full text

Biological characterization of PM226, a chromenoisoxazole, as a selective CB2 receptor agonist with neuroprotective profile

María Gómez‐Cañas, Paula Morales, Laura García‐Toscano et al. · Pharmacological Research · 2016 · 31 citations

Inactivation of the CB<sub>2</sub> receptor accelerated the neuropathological deterioration in TDP‐43 transgenic mice, a model of amyotrophic lateral sclerosis

Carmen Rodríguez‐Cueto, Marta Gómez‐Almería, Laura García‐Toscano et al. · Brain Pathology · 2021 · 20 citations · Full text

Rows per page

1–5 of 7